Indocid (Indometacin)

Indomethacin blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, it reduces inflammation, pain, and fever at the affected site.

The appropriate dose of Indocid is determined by the prescribing healthcare professional based on the specific indication, severity of symptoms, patient age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions exactly.

The safety of indomethacin in pregnancy and lactation has not been definitively established. It is generally avoided in the third trimester because of potential fetal risks, and breastfeeding mothers should consult their physician before use.

To request Indocid, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Indocid (indomethacin) is a potent non‑selective NSAID with strong anti‑inflammatory activity, often considered more effective for certain gout attacks and severe arthritis than milder agents like ibuprofen. However, its higher risk of gastrointestinal and renal side effects may lead clinicians to choose alternative NSAIDs for patients with those concerns.

Indocid should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not store it in bathrooms or other humid environments.

Indocid is supplied as an oral formulation that should be swallowed whole with a full glass of water. It can be taken with food or milk to lessen stomach irritation, but patients must follow the dosing schedule prescribed by their healthcare provider.

The most serious adverse events linked to Indocid include gastrointestinal ulceration or bleeding, severe renal impairment, and life‑threatening hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should be monitored closely for any signs of these complications.

Indocid is contraindicated in individuals with known hypersensitivity to indomethacin or other NSAIDs, active gastrointestinal ulcers, severe renal or hepatic impairment, and in the third trimester of pregnancy. It should also be used with caution in patients taking anticoagulants or other drugs that increase bleeding risk.